Navigation Links
Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer
Date:7/29/2009

BIRMINGHAM, Ala., July 29 /PRNewswire/ -- Michael Cobble, M.D., director of Canyons Medical Center in Sandy, Utah, has been appointed as Chief Medical Officer of Atherotech, Inc.

Cobble is a primary care physician, board-certified lipidologist and certified hypertension specialist. His responsibilities at the Birmingham-based cardiodiagnostic company will include educating the public and health care professionals about Atherotech's line of cardiometabolic tests. He'll also be responsible for furthering understanding and acceptance of the VAP(R) (Vertical Auto Profile) Cholesterol Test in advanced lipid testing.

Cobble succeeds James Ehrlich, M.D., who will continue to serve as a medical consultant to Atherotech while pursuing advocacy efforts for the early detection and prevention of heart disease.

"We are honored to have such a respected and passionate champion of cardiovascular health join our team," said Atherotech President and CEO Mike Mullen. "Dr. Cobble engages in clinical research and medical education to advance the understanding of cardiovascular disease, yet much of his time is spent in the real world of direct patient care and interaction. This constitutes a unique skill set that will be highly beneficial to Atherotech."

Cobble will maintain his role at Canyons Medical Center and continue to practice a full range of medicine, including diabetes care, cardiovascular disease, hypertension, dyslipidemia, and bipolar and mood disorders.

"I'm excited to join Atherotech with their dedication to lipid assessment and risk management," said Cobble. "Too many cardiovascular events continue to occur in 'low risk' as well as 'high risk' individuals, pointing to the fact that diagnostic testing and treatments need further research and focus. The VAP lipid test has been a powerful tool in our clinic and thousands of others for both risk assessments and treatments complementing valuable patient care."

Cobble is a member of the American Academy of Family Practice and a board member as well as secretary for the Pacific Lipid Association. He is a member of the National Lipid Association, a board-certified clinical lipidologist and fellow of the National Lipid Association. He is also a member of the American Society of Hypertension and is recognized as a clinical hypertension specialist.

Since completing medical school and residency in the early '90s, he has obtained a master's degree in psychopharmacology, and his practice is a referral clinic for the Harvard Bipolar Research Group. He lectures extensively and has published articles on topics ranging from pathophysiology and lipidology to the treatment of diabetes.

Atherotech developed and markets the VAP Cholesterol Test, available nationwide, which reports 20 separate components of blood compared to just four in the standard cholesterol test. The VAP Test has been identified by Forbes.com as one of "Ten Ways to Live Longer" and recognized by the Wall Street Journal as one of "Five Tests Worth Paying For."

The company also provides more than a dozen cardiovascular and metabolic testing panels, including

C-Reactive Protein (hsCRP), ApoE genotype and NT-proBNP for assessment of patients at intermediate to high risk of cardiometabolic diseases. Atherotech continues to add advanced and follow-up cardiovascular disease (CVD) risk profiles.

About Atherotech, Inc.

Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.thevaptest.com.


'/>"/>
SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
2. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
3. Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
4. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
5. Atherotech to Exhibit the VAP Test at Internal Medicine 2008
6. VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
7. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
8. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
9. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
10. Atherotech Unveils New Cardiometabolic Test Panels
11. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):